\ fltfff,{ffiq gNQq tc[|-i,qt4qeqr

mqi6loTr$.S.rry.fr,/zozt /g 1 /sfr,

1. wrw o-A-ffi, q.q I

2. srrw sTDETdr, fr'fu-ffir q-6rfuqrd-q, q.s I

3. wrtffi gw ftfoer qq wNQq srffi, q.s t

4, sirftI frfuf, $fq sE 5q q$f,ld orftro, q.q I

fiqrd, ft{io 2T/os/zozt

frqq:- ffii€Tq .** gl: r{rnfra qhilq\ 1rq 'pft s-6-r"it d TTfi d G.non,.

Sequencingd ffil frtr4q{:- dqra-qrfi-{r-{ Tr ffi'.,/oTl-$.S.gq'.fr./2ozo/zos3 fiqrd ft-{ier $/12/2020

frEqro,In a-g. t fu reer t otfr.s-re fiqt-rm-ivt. t-g q-f,{€rTt cil-{a {{{flI @t

qrffi f{ffi d orgux EfrRqd fr,qr qr q6T C' \rq 3nq Rrio iltr qG 30,ee,5oo t-qer

dT{ q-d(, q-d ar$q qd-q, oo q{ t siBo sq d qk. itrl 45 q{ t 3rB6 Co-morbid

qfu qfrqfu-a t t qa ter rqT fu 6ft-rq q-m-wil d otBs ffi-iq{ d z e)q flw 6ri '

d qyqrd fi tnifr--s-1e q,-T gq: {rm-quT ggn t I qd lgqq B fu tt !-fl"fr t @HqT qlrrrs

d qqw i E.earq E3rT d I sARS coYZA *iqrfuo r$ q-f,rfr fr qrci{fl d E-f,fq, Cifr-66)s, qarTq enft w 3Tqq.q tg FruqrR frdaT Rr qr-i t'-. o}fue-rg d wrtkr gdq-in.q"r A qrnfuf, tro-{"it gq r.fr{ Iro-{"il d T{i Genome

sequencing tg nRil fuq qrt t

o gs fu qltfus ffiivrq srq qfrnrqt ti nvsanr d aeryr M ti qq o'Ifus q,1

qra & q1{r fuqr qr} 1'q um qrr qififtq qr} qri qr l{Efuil e-q Ehl qfrffi fuqrqri

r

. Tf,i'T riT6,T o1 6Tffi Td q R\ -rq Frffi o-l q?rl fr=Trgirn gfrkqd fuqT sd'-

o r{il q-,r6rT qfi o-rffi qfrTfs-a qrrq q-trrsrq (frfu-trT erfffiZd-qt=ffiRrq-q/v<rq qq{) gm fr.fi{ fu-e lruttComponent)q-6=Eq fu-ql qdI

o Genome Sequencing i-g \-f Oro-pharyngeal i-ell Vfi Naso-pharyngeal Swab cF-l Tiq-6tT,

3 mlvrMtubeti en$qfr.qq.3Tri 6 prffi qtT slEll'o€ gf \-f,hd o1 qrito sqq qRTfu G-g m. 4 gq s fr s-Ffd 3rd'ffiq utM d em.fr.fr.qfr.Gil( .ilrq d fr\

vrM tube t ft\ qq e-qd fr * r mlsrqd, em.fr.ft.rft.3TR qfrrr:TrdlC arT grf,aliquot O-g -800 C W Deep Freezer ti fr."r" fuqT .ilt t efn.0.ft.el-{. \flfq ffi-dm-frfr-q eni w gu durft-o 1 61frq"6 C G.no*. Sequencing tg ftrcrfuT RGSL

t Qqd-aw Sfur o-r Dry rce t oisrc +{ gBR-dd o-ri g\ riqr qnr eir t

o r1T{d q1.1-m-R ilq qlaT tg ftrcIfuT Regional Genome Sequencing Laboratories (RGSL) O-T

fr-f,i"r frET5qlIq t-I NCDC, Delhi - Division of Bio-technology, Epidemiology & Central

Surveillance Unit (Estimated Sequencing Capacity - 3000 per month)Eastern part ofMP

2, ICMR - National Institue of Virology (NM), Pune

DBT National Center from Cell Science, Pune (Estimated

Sequencing Capacity - 1200 per month)

Western part ofMP

. frfu-el q-6rft-il8-frq lqfqyTrdTon gNT ?Trga {r{q,-r{ e-m ftr;aifu-o RGSL fr q$ +tGenome Sequencing d frI qRq-6q q-{ €?ilB-d qq et qftqffi & o'ql" vqneq frerq

o\ gfflq i-fl qri I q-r<rqT d .rfterq Bqqd Urrdl{ q,1 offi Re-imbursement mode

ii pvn code B.31.t.t"CoVID-19 Diagnostics" fr Tfr-E( cwe qrRr t gfrR"-d of wt-,ft t

@ gq sfrq. EIB4 \ @ Rtq HiT qgtfu

'9=:-(d,. ffiq ril{i{)

,D-qf6 / qd.O.gs.fr ,/ z ozt / 915sfrftft'- qmef t

3Tr$ffi ENQ2I,qsqq-tqT

-nqrd, ltq 9Ttos/zozt

t. oTfrftffi gcq rflfuq, do wrwq gq qk{R ?D-c{ttq ftqFT, q'Trf,q, qsc'lrT +r{q, q.g I

2. oTrgcffi, frfu-ffiT frfuffiI RIqn f{tn'T, sdggl ll-tl-{, q.q I

3. ftYrq $arcr6, g{.\'q.\rq., q.q I

4. trrrffi Tirlrftq oTrgffi, q.q I

s. Hqrdo, frfu-trT RIeil frqFT, q.q I

6. rrrrtr etfiq Tiqrd6, RN€zI ffi, q.q t

t. rrrrftr fudr wffq eiffi, q.q t

8. ssrffi mar gftEFrqHfrre /sra tiqq, q.s t

e. qlTlt, olfrs-rg frrielT $q{, sqrErilEt-q ENezI ffiI, q.s I

rzE-3Trgffif wNeq,

qtqqtvr

\{qqT"Ifilq gxgezl ffiqtqraqr

rqi6lsn{.S.qs.fr / zozo,zd-0 9 5

sh,

frqttT, ftHio, eS / lz/zozo

1. gtrtr 6d-.8-r, q.q I

z. HrrfiT GTBsrdI trrsfrtq frfrffir qgftry6u rI'91

3. srrff gw ftfarer \ni wmq erffi, q.s t

4. srrfiT fqffd wfr se 5q srsliTrd efrr6, q's I

Evg:- SARS CoV-2 Virus frt T{ q-UTrfr at sTia tg G.no-ic Surveillan." d ffiq it frqT f{d1T I

tr {,- l. -*g.*.W.oIR,

ENezI ot-d{ieiTq fflTr.r gg urfr "sepcimen Collection, Packaging &

Transport guidelines for Cenome Sequencing of SARS CoV2 at Points of Entry"'

2. +rr{cr qffi: ffi; G of* o_"urT Tdffiq of ve,TrFrdr gffi Indian sARS-co v-2

Genomics consortium (rNSAcoG; gr{r qrft qw[iq: "Genomic surveillance for SARS cov-2

in India"s. qqffi{rtrfr{ q-{ ffi. /3rr{.0.gs.fr. /2s77 ftiqtq' zz /'tz / zozo

6,,,u.in d-s t fu X-{€;-s fti{--q t qfrtp-f, 'ARS

cov-2 virusd n$ q-flft *1 sfum

ig-i gi q-6 3r.ira 3iltlYrm t fu qrso ii ilT{s d v-on s mieT fr flrlEI ffid q'-{i tg"fcnftq; g{erq" (Genomic Surveillance) e1 uTt I {g tg Indian SARS-co v-2 Genomics consortium

GNSACOG) Arsr Tf,n qfr d-q q'{ qlq-{s d qqorq, difro ots, qellq erR w elqqq frtql

"lt- oen ffiq d 3r-getrTq Ag fi olffi *1 qr}'.t

t

SARS CoV-2 Virus qfi r-i q-$Trfr d G"rorn. Sequencing < frruq-R ftftT frq \JIri t'-

t. ffiruu 23 ;ltffiN zozo t zz frsqt 2o2o A qq Wr{& ffirrsq t qr;rr 6{i qre/f**iqrd mmfgq qd .rn vrd-sfr{rd Grffiq qBrqI a1 c"nr-e sequencins tg =W} a1 qtq

oqr{ qri t

z. ffir{ frq-d fr .Tr.r ti qre 3lelfl ffi{ HK fuq Eq dfrG-rg fr-frEq qftilqf + q1-fr

of ft Genome Sequencing tbalfi qrqr *fi t

3. o1fus-rg $fiquT'A qfu6rs qre g{,ffid (Re-infection)gq mfrf-e qrn Tn qfrilqI ft

SARS CoV-2 Virus frt T{ rqrfr ilqI frtrqq at dqr{{r dI Frd rqf gg Genome

Sequencing tD-*r{ qr} t

4. ffiiuo 23 ;ftffi1-t 2o2o A qwrf, qrrd oili Hrrw o'ffus-rg mmfrs 3iiltrlq qrBrqt +

rrf,-qfrsrd rqt cenome Sequencing d fuq nfud fug qri t

k{i6 og frsqt - zz ftmqq 2020 d qEq qrgf, sTrt t-fr 3ffiq qrfr ffi o}fus-rg d

65q sfuiR-f, iii \q 3TR.4.fi.fi.3TR. qiq qf-fiEq dt, a rxi c"ro-e S-equencins t-g tdqrt t gqw sral atrq 1fud qrffif a .,1iq q{i qr{fi.\FI.3TR. .rr$g-dr{q 3rgfiR T-ryr{qd k{i6 d s t - 10 t ffi A @ fuq *O gu 3Tn.A.ft'fi'3rx' qiq trSfuq qrn qri

w Br1-d qi ft Genome Sequencing fu N urn t

q1qf, ssil{ Er{r k{i6 23 "ltl-ftI-{ zozJd swl<T m-fiEq qrn 'r} Irrrffi qfrilqf fr t t€q

oflErR qt frr€ifuf, s"7, qfrrdt d qf,fi 61 G.no-e Sequencins A fuq ftF€ifu-d frtqr i1rhn

6*61 61 vrw ftil-dt d *.rer rroor'H{dq oTffi iln sfsr qfi qr}rft1il{rgffi{, qqBilqt a .o qfi in;rr gd cenome sequencins tg T{-r\ q''I iqur fucTr H+tq 3Tffianr EfrRa-d of qri t

5.

7. q1gA HI.FN Et-iT q-eyf & frEIfud Regional Genome Sequencing Laboratories (RGSL) o'f fuflur

fr<r1uri t:-1.

2.

ffi of Bio-technology, Epidemiology & Central

surveillance Unit (Estimated Sequencing Capacity - 3000 per month)

Eastern part of MP(Gwalior,Chambal,Sagar,Shahdol, Rewa,

Jabalpur Division)

ICMR - National Institue of Virology (NIV), Pune

DBT - National center from cell Science, Pune (Estimated Sequencing

Capacity - 1200 Per month)

Western part of MP

(Indore, Ujjain,Bhopal,Hoshangabad

Division)

8. qTtt 6r V6*o{q \,ti qR{F{ - Td g aq-6 vs-S-srur d .{deT i urt ftqT f{{rT 3i-5HN fr

la+ or {Ei-{slc[ gfrPqf, fu-qr qmr t r ein.fr.ft.fr.ern. qrq A ,Ti-ft fr Genome Sequencing

d"fuq {f,+ oT qqE"T, iieTxur qq qR-df,{ ftqEsR trfrkqd o1 Ed'-i. r{qr sq-6.T of 6r-ffi qfu|fa qgq lnsrErq (fufu-trT s{ffiiZdq t-ffiR'rfi/Ers

ogl *" fi.ft.{ fo-e Gutl component) qf,{Ex fo-qr srt t

ii. Genome Sequencing *g q-f Oro-pharyngeal deIT V6 Naso-pharyngeal Swab ch-l qq-6"1, : mt

VrMtubefr qT{frgq3il-{ d frffi 6-l rllcl=T EF-{i gq \-6-kd of uritiii. sq{ E?rtq ffi m. 4 1'q 5 i qFfd 3ffiffiu qTM d enq.E.ft.fr.eirq ulq A ftq

vrM tube fr frq ]l.g Qqd q t 1 ml ff{ET, orR.a.ft.fr.ein qdrrflTdrcn gnT g1_f,

aliquot q,s -800 c rt Deep Freezer ii fr..r" fuqT qti t erx.d.ft.erx. qiq ffid m-frEq

eni w ge uurfto 1 ml tqET o\ G"nor" Sequencing & fr-€Tfu-d RGSL ti gq6-6"ffifrrT q'{ Dry rce t[ otre +{ gfrkdd ori gs qUlT Uirqr EIrn I

frrar w< q{ 3il-.x-{q-6 sqrt-q *q q,,Trft erffizerBwror frfusT q-ETfunrf,-q d qTeI

gftR-qn of crt t

10. ftfrrffir T6rffi{ EM q1gf, sra;'R g1gr frr€ifr'-d RGSL t TT{t qft Geno-"

Sequencing d ftTq qRT6{ qr ${Tfrd qq a1 sffi fu engm, frfrffir frrafl * ulqq *{rE!1-q ERaq fu1q o} s-srq tmr qrn I rKrqT d qtq{T swltT 5Tlilq d orffiRe-imbursement mode fr run code B.31.l.1,,covrD-19 Diagnostics" tl fr{il cqe qRr tEfrkqf, o1 qTt ft I qam{!Tq,. qSiJ' 61c"ro*" Sequencing tg 96, srer ftiaifricT RGSL fr t}-Sr

qrg drfu qRil6{ qq qrat G t

erw Tq qfuq, rgNQ{ \'q ftfu-igr RrmI gnr on-TdP{a

4,ffi3Trgffi ENeq,

qt4rt{r

mqi6linr{.dI.\'s.fi,/z ozo / Sqrd' ffri6 / rz / zozo

sftftTfr'- qf,{ref t

1. .fdp#'5eu qfuq, fo sreq \'{ qRflq 6eIM f{tTrr, {Tffiq, ffiItT ffrJT' q's I

z. oTrgffi, ftiRtffiI RIffir fti{r'r, sdggr qtFT, q'q I

3. ftqH €qrffi, w.w.gq., q.s I

4. srrff tiqrrfrq ctrgffi, q.g I

s. frqrmo, frm, \F.w.gq, q.s I

6. Sqrmo., frfrffir Rrgt fttn'r, q.q I

t. TrrrKT fftq riamo, ENe{ ffiI, q.s I

8. srrfiT ffar fifrRffitfue, F.W.S., q.s I

;: *rfi, olfrs-rg ft{iT'r ?DH, \{aleriltrq FrNerI qu,il' q's I

durgff FrRzI,. wrt{r

i1-qfc4-{ftrq ENQ:[ ffiffqrtqr

mqttn /on$.$.gs.fr / z o2a / g_o7 4

sfr,

-nqrf,, ftrnis 2-2*/ tz/zozo

l. vrrkT o-teq, q.q I

?. srrffi Uq 6rdqrd-q oTM, fulrr riqnrrr//wrqE qqrrrc, q.s I

3. srrw gq frfuffiT qe wnea ffi, q.s I

1. rrrnd fuE-s ffitq ise Tq erersra stftr-q, q.o,

frq-q:- sAlls cov-2 virus er1 T{ rytr q qrydts ftiq-sq (*d ) fr pq1ffi { srqr;nqfifrfrqHRr.m v{wq W qfrfrqr ig qrr rft*", frg; r '

w+{:- i. glrfl HTol{, Ere,q \q qft{R 6-g1u1-qa16q Ern rrrfi ftftT M-o zt,/,tz/zozo2' Hfuq, gTTf, rrfiFrt-Rrrsq gq qfrffi EE-cdIIut q"Idq or o*qTrqoto q,{ F-. Do No. Z-

2t020/16/2020_pH R"il6 zt / tz/zozo

frq-qrodn ds B fu Wrtls fri.T€q ilT frqq Er{ez ri,l-dq 6,r fu\ ,Iq qfra_fi oi3-flR sAnsco\/-2Viiusthl r-$ !-qft (Varia,tu,derrnvestigation-vur- 20zr2r0r).m ft-6f6-q fu-qr r?TI {l uuror*r,.,Center {br Disease Control (ECDC) Af$ Cffi qWfr oits6 TtFrfifi Vq gsT rR5-qTq qn qaITfr-d O-qi q|ElsrqT r-qT tt snnsCov2d q-fi-q qqrfr t Eqr{ qrx d €frETH ild qt.Brcil d orqq qrrd t qillnerrtrr"T qfrEflffi q{ r}mr etqr qiqrhiT t r

?il-{d q-{fr-R gr{t 5$}s friqsq t ffi.n zs fu$q{ t er krrrerq 2020 d rrtq eil'a qldHqr{ B-BrqT o} eTrnft 3lr+YI dtn' snalr$ irq t r{q fu-fi qqr B I rrflE"rft S $eq t q-d-d-dl $r {erTfri,s-o gq Wrfds ftnTcq t oTri ffirf-**f sr-A qq-{f, orf,-{ffiq qrfun 6-T q1-qfr d Fdr$ ors--s q-{3ilrTrr{ Btr{lrl 3m.f.fi,fr.em qrs ffiT{ v.r}.ft I frf+r E-{ri elqdi qq fr{id6 21-23 Rrflqr 2o2o s-{3rJTq-q Bwl"rT ritfrBq qi w q-rmt d v'rro "rnd" (frq W d ) .Fi rT{eTrrm qsrrcif,{ q-s .t-fiibq qi?TTi qE 3ilg.Sqq.em. ftffi s 3rgsq 3reltrT d&TUr vdrq eii.rq iBe-re aff qrs o1 snq,f}

r

'Tq-fiT" o1 gn:tT s?F'{ut d s qfrfl T{, q.rcq riftu oen s qfu qd td qE qrM d sq i qfuil-R-flmrd gr dB-{-q aEr frrrifr;-o frrm qr}ilT

I

w-rT-qil o\ gE-rd virfr gq fr.fl:rrR qr+6 qftqlaq qfuqT frefkd si q'rft t,-l. rcm-el @ftlTo. 25 frtfeft zozo tt za kwrarq zozo d mu {q.r$]s furTs]r

1'f ITTTd' d n'n-- Eo,ri 3r.s-di tr{ 3rri qld 3ffif$q qTffir frt q.fr Rureau of Inrrligr.arion ETIT T[erngg1,T{Tft {fte o} stra"q ?F-{ri q.rhft ftr*i n-'q qdA<r o{iknTtl di-qt Hrtrfl ftr,qT ih qr:r'itiETl dT u'rq-.tt:-ir ii-rllHlq sTFTrrq qr fr'-ffBq qd rrd ?Trffii \q {jq.d i erd tr6 qrBrq\ o\ cr"q ytrcr.J tt';

,T{ht.fr sJtEFIftdi Erv $renrrn qqffq/sn*lrirrc d=a\ qq 1S o1 sfrn ra-mrrr qi'l

.;]pl I

l:. rrhltht ;:.tryf{qq m r+q ftT irrft eff S{, ,,n" .f1;nq 1 ffi r+t 1?=r firq..l r1,i ,ili,f i,: I

qT7{r nlfclT E (II, -trJ;1 (q nil ft+q vffq vta iTcI zq \Tt zR orcfsliq \I'] l?fq ri\ ;: rT{1r11 .,;'.'ti ., I

,lf{olpr ,,riq1eA,, q in t

{.:. 'mld.t.rh.'1tl.rnt ";nq qrTft.{.lR"rfq::n<i rtrErui mj z ft.rlr ri; fi-}\ iit,r m$t)iii1'1 i 11"r;) .;'l

T'ti1ri frl;il:;inil 3n{ S;fh .larrir ,ri) F.tfrt;ernritrr l.l-qcr"t'i $F\fimr16) ';ttr) t

ri r:lr{ rtT:i.1li4:rl:t,b Z filqdlrt Ult{il ri; q,gq1,ii lfn.ri'l.rllftl.u.ttl.,tl\ rl;[: ,.ili,1 ;1')1 .;111i r].i i;fl.q

,fl,rrr1:rJ .trt"i,:.t :lttjl .t{ ,lrt ittaivttilt:ltt q;t {lqlrd lil,rtr .;ttr't I

c. iT{ slqlI ii IlrIftrd i.fl,q qErr .} TrTnn ti'n* ,:riw ,i .lfl,r.r Tr i{Fileil prAi rR urftin f,r;rutlq I

r'. r-fl t{ iirnfdrq;N ;i; i<.rr{ o{q.ul t ad}mrf{rl oi n.ore nrJftn {i{rfi ri i,q-tfr'o Trtllfr"n,i,g'ri q.t wdeni q,n\ dl arr{efi dt "rri t

s. srrsrildldllrrs ,.iim q{trfl S qfr".rrf, qTf#i.b fe\ sFnn ond*{iTd?F -.fr tuirqedr Uftfrarrr.li "r.i t

t. ${dq f,efi $tq}-orq rrftfrfud- kffm 2s tmt1q zozo t zs Rqr?q Zazo 6 tttu zXild"s fih'-r'e'I

ii qiro .i ltit=r 6qr$ oigl*f q-q CIri are u-otslrr riil*il qt l],,r*u,, ol'lrrrrrrigratio'r rl Nf{ rlzlJ

iit--1flT( lbet sf,q w ftrarym n-iA;q npl tfien-etq rrftfr&"fi u1 "6t:-r fiiar ffiI tr{ erntdf, q* t q GIR,fi fi qfi 3{T{ GII" +,}Bq qTd ?TrBd qi Eh{ cn-$awi

'1

tl'.'l'l q-q g.lqi ffi.i; fiffi si qrq t,. .*- *---.i rr*-, ,.l rnfxit u; qEfrfr G{r*q]Iay6. ft-TiT-ff Vq orm,q ffirF -cn'z flzr:nIl. rrrir"ll tl{rl{l

elRFfr ;r,rsdiriITI$rq. q.E..fr Q gq' mrd r,fi qfu-qT qfrtt"H +t;r.rq t

'-i:r *"' '51fi u;fi q z Feilfi [ri- d-r O gi aer"r om+eo El n'T ileTUT sflft fin'rm qq d]til. Jll( \tl i(h

.irr s CI rtl dJ :m Efr qtz gftfrsfr al ralq r

ir. ilcq qr,q ,*,"t qrdr in-{r ql-A N fuqff ?fi qn1 uX sri-mTff c@-TFI qtifhd qr"q d,qfirotRrn a;t fr wt t

\. qft fr)d rn- qpo{ rt oTarqT rrtar-w d dmn cq'FrfiT a} rql 6\ fr\, ftT-dT 11-tr<] orfttnrft

E1r{T f,FF-td Yr'J{i $?td."{-{ 3lffi 6T qftTfr ft;ql wz) t

r i. trte-{ qr* E} q{ q{ ftqffi{f, ** ,n-orna ff{rdt cajn srrw sl5qrft-6 'Tirl-mJ" of fuffiqi iilri 1'q rtqd k{16 s s t ro i k+s d mq rqftffi eil{.$.qq.cr{lY. .n{€-d{r{q 31"Jqn

s{a&r aeTq tsffiT dri .rq d65ra eTn.E.ff.fr.orx. qqfu t iiliq ?F-{i dt qq-sdqT fi qr} t

ffi-rffi/ord.s.qs.,fr/zs2s / 2-o7 8

-J-*u'"C- *--

- {}GT. fici-q 'ilqa)3Trgifl rsNsq,

qt4s+qT

-nqrf,, ft-{i6 22-/ 12 / zozo

06ffi:- q'qqTeil ^ _1 $frRuffi' gr3q qfuq, fro wneq qrq qR-{R ir-c{rur fraffi, qaffiq, qc('lq ltq?i, q'q I

2. s{rg.m, frhiqT ft-frffi1 frHT fr'ffT, sfl5.sr cffi{' q'q I

3 frYTq riilFrfr, Y{.w'Yq', q"'s I

1. q-q'{f, sflrftq 3rgffi, q q I

5. Trqtfr' e}*q q-flf,-fi, lsr+ea ffi, q'q'l

; rrt, otns*rg FrqroT os, qrarc;nerq Enezi ffit' q'e't

_i- ( 1., .. I'

3{fg.l\f WNtr;,nq'r.lils

v'rEA( r,*Viffid.a''**trffi*wxw$s.(l,t, To+tt${pram

vrdvrwftrq

N$[sr, err{xq-$

RAJESH BHU$HAN, IA$SECIRETARY

)w^-- #"Mgr*r*,It has been reported that a distinct Phylogenetic cluster of SARs-CoV-2 variant has

been detected. This SARS-CoV-2 variant-is spreading & growing rapidly in UniteclKingdorn. It has also been reportecl that this variant has an unusually large number qfgenetic changes particularly in the spike protein. This development calls for enhanceclepidemiological surveillance, enhanced containment & other measures to effectivelytackle the challenge.

2. As you are aware, India has been seeing a sustainecl clecline in the number of fi'eshCovid-l9 cases for over 2 t/z months now, accompaniecl by a decline in the number oldeaths. In this scenArio, any interjection of a SARS-CoV-2 variant virus throgghpassengers with air travel history cor"rld pose critical risks for pandemic managen:ent inInclia.

3' In this connection, based otr the inputs reoeived tlom the .loint Monitoring Group(.IMG) headed by the Director General of Health services (DGHS) and the Vaccine I'askForce headed by the Principal Scientific Advisor and Member (Healrh), NITI, thefollorving is proposed:-

1. Immediate steps

(i) As a $leasure of abundant caution, passengers arriving ti.orn U,K in allinternational flights (flights in transit) ihould be subjecte-d ro mandatory R1'PCR tests on arrival at the airporls concerned.

tdrftr w$ri{Kffieq y{ qRqx w-cdnur eqTTKr[qrr \:{ qksm &Ensi q$mq

Governnrent of lndiaDe partment of Health and Family We lfar*

Ministry of Health ancl Fanrily Welfare

D.O No. Z-2 I 0201 l_6i2020-PH2l't December 2020

a' Those rvho are found positive on arrival must be sent for institutionalquarantine/isolation set up by the State/UT Governments, in collaboratiolwith the States/UTs concerned.

b. Those who are found negative in RT-PCR tests should be advised to isolatethemselves at home for seven days, to be medically monitorecl by theStatesfuTs concerned.

c. I{elevant inforrnation in this regard may be prominently clisplayed in arrivalarea, waiting area of thc airports.

contd.?/-

Room No. 15S, A-Wing, Nirman Bhawan, New Delhi_110 011Tele;(o) 011-230618s3,23063411, Fax;011-23061zsi, E-mait :secylrfw@nic,in

-:2:-

(ii) Kindly coordinate with the airport authorities in your jurisdiction to urgentlyset r"tp adequate number of help desks, manned b1, State/UT perseinnel at theairports to facilitate this exercise,

(iii) Adequate arrangements for passengers rvaiting tbr their RT PCR test resultsmay also be made at the airports in corrjunction with the airport authorities.

2. SFrveillance and follow,un meqsures

(i) The surveillance teams should be given a clear mandate and action plan forphysical monitoring of all those who have tested negative in the RT-PCR testand are under home isolation. The tean:s should ensure their proper isolation,monitoring of paranteters and ensure follow up RT-PCR test after 7 days ofdisembarkation.

(ii) In case any such persons develop symptoms before seven days, they must betested immediately.

states may, however, take additional steps as per local requirements.

Yours sincerel.v,

(Rajesh Bhushan)

To rChief Secretaries/Administrators of all States/UTs

Copy ibr inlorrnation to : Additional Chief Secretary/Principal Secretarylsecretarv,Health - Al[ States/UTs